Prof Mamun Al Mahtab

The writer is the chief of Interventional Hepatology Division, Bangabandhu Sheikh Mujib Medical University and a member of Strategic and Technical Advisory Group, WHO-SEAR.

Time to rethink Ivermectin in Covid-19 treatment?

After the emergence of the pandemic, several repurposed antiviral drugs such as hydroxychloroquine, ivermectin, favipiravir, remdesivir, nitazoxanide, and lopinavir/ritonavir were provided emergency authorisation approval as there was no direct antiviral drug for Covid-19

3y ago

Not required debate on vaccine superiority

Around this time last year, people all around the world were anxiously waiting for the Covid-19 vaccine.

3y ago

Covid-19’s impact on liver

Since December 2019, the world is learning to adapt to a new normal and at the same time, new words are being introduced into our vocabulary regularly.

3y ago
September 14, 2021
September 14, 2021

Time to rethink Ivermectin in Covid-19 treatment?

After the emergence of the pandemic, several repurposed antiviral drugs such as hydroxychloroquine, ivermectin, favipiravir, remdesivir, nitazoxanide, and lopinavir/ritonavir were provided emergency authorisation approval as there was no direct antiviral drug for Covid-19

September 12, 2021
September 12, 2021

Not required debate on vaccine superiority

Around this time last year, people all around the world were anxiously waiting for the Covid-19 vaccine.

August 23, 2021
August 23, 2021

Covid-19’s impact on liver

Since December 2019, the world is learning to adapt to a new normal and at the same time, new words are being introduced into our vocabulary regularly.